Spacer
Spacer
SEARCH
Spacer
Spacer
Quotes News NAV
Spacer
Spacer
Spacer
Spacer
Spacer
Financial Ratios Markets  >  Corporate Information  >   Financial Ratios
Spacer
Aurobindo Pharma Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
524804 INE406A01037 406.2420157 AUROPHARMA 0.22 103,395.41 37.63 47.76 1
Your Result on : Markets | Equity | Corporate Information | Financial Ratios
ParticularsMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Debt-Equity Ratio0.210.190.190.170.18
Long Term Debt-Equity Ratio0.010.010.000.000.00
Current Ratio1.161.251.401.741.89
Fixed Assets2.522.642.081.421.80
Inventory4.734.633.282.262.75
Debtors2.662.742.551.982.28
Interest Cover Ratio15.8411.2514.4622.6797.66
PBIDTM (%)32.7826.3927.1922.8718.34
PBITM (%)30.2323.6824.7919.9914.66
PBDTM (%)30.8724.2925.4721.9818.19
CPM (%)24.1718.7020.7517.3916.57
APATM (%)21.6215.9818.3614.5112.89
ROCE (%)12.9110.8211.748.188.49
RONW (%)11.178.6810.356.988.81
Spacer